QUANTITATIVE ASSESSMENT OF LIVER FAT FRACTION USING MRI-PDFF AND CT-ATTENUATION: A CORRELATION STUDY WITH VISCERAL ADIPOSITY IN THE INDUSTRIAL WORKFORCE OF WEST BENGAL
Main Article Content
Keywords
MRI-PDFF, CT-Attenuation, Visceral Adiposity Index, Industrial Health, West Bengal, Steatosis.
Abstract
Background: In the industrial corridors of West Bengal, the "thin-fat" South Asian phenotype presents a high risk for metabolic-associated steatotic liver disease (MASLD), often despite a normal Body Mass Index (BMI). While ultrasonography is a common screening tool, it lacks the precision required for quantifying early-stage fat infiltration. This study evaluates the efficacy of MRI-Proton Density Fat Fraction (MRI-PDFF) and CT-Attenuation as high-precision quantitative markers for liver fat, correlating these findings with visceral adiposity in an industrial cohort.
Methods: A cross-sectional study was conducted at a tertiary care center in Durgapur involving 120 industrial workers (aged 30–55 years). Participants underwent NCCT (Non-Contrast Computed Tomography) to measure hepatic attenuation in Hounsfield Units (HU) and MRI-PDFF using a multi-echo gradient-recalled echo sequence to map the fat fraction percentage. Visceral Adiposity was calculated using the Visceral Adiposity Index (VAI), integrating waist circumference, triglycerides, and HDL levels.
Results: The mean MRI-PDFF in the cohort was 14.2% ± 6.8%. A strong inverse correlation was observed between MRI-PDFF and CT-attenuation (r = -0.84, p < 0.001). Furthermore, VAI demonstrated a significant positive correlation with the MRI-quantified fat fraction (r = 0.76, p < 0.001). Interestingly, 32% of participants with a BMI < 23\,kg/m^2 exhibited an MRI-PDFF > 10\%, indicating significant "hidden" steatosis. CT-attenuation showed a sensitivity of 82% in detecting steatosis compared to the MRI-PDFF gold standard.
Conclusion: MRI-PDFF provides superior quantitative precision in detecting early metabolic dysfunction in industrial workers compared to traditional imaging. The strong correlation between VAI and liver fat fraction suggests that visceral fat accumulation is the primary driver of hepatic steatosis in this population. For high-risk industrial screening in West Bengal, MRI-PDFF should be considered the definitive non-invasive biomarker for monitoring disease progression and intervention efficacy.
References
2. Tang, A., et al. (2013). "Nonalcoholic fatty liver disease: MR imaging of liver fat content—from bench to bedside." Radiology, 267(3), 656-677.
3. Idilman, I. S., et al. (2013). "Hepatic steatosis: estimation of the fraction of fat with multi-echo and T2*-corrected chemical shift handling MRI." Abdominal Imaging, 38(6), 1277-1286.
4. Kodama, Y., et al. (2007). "Quantitative evaluation of hepatic steatosis with CT: Comparison with histology and US." Radiology, 245(2), 462-471. (Establishes the Liver-to-Spleen attenuation ratio).
5. Park, S. H., et al. (2006). "Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative evaluation." Radiology, 239(1), 105-112.
6. Amato, M. C., et al. (2010). "Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk." Diabetes Care, 33(4), 920-922.
7. Després, J. P., & Lemieux, I. (2006). "Abdominal obesity and metabolic syndrome." Nature, 444(7121), 881-887. (Explains the "Portal Theory" of fat).
8. Rinella, M. E., et al. (2023). "A multi-society Delphi consensus statement on new nomenclature for steatotic liver disease." Hepatology, 78(6), 1966-1980. (Defines the shift from NAFLD to MASLD).
9. Vaisman, N., et al. (2012). "Visceral adiposity index is a better predictor of liver fat content than Body Mass Index." Clinical Nutrition, 31(6), 901-905.
10. Tchernof, A., & Després, J. P. (2013). "Pathophysiology of human visceral obesity: an update." Physiological Reviews, 93(1), 359-404.
11. Misra, A., & Khurana, L. (2009). "The metabolic syndrome in South Asians: epidemiology, determinants, and management." Metabolic Syndrome and Related Disorders, 7(6), 497-514. (Contextualizes the "Thin-Fat Indian").
12. Deepa, M., et al. (2007). "A high percentage of overweight in the urban population is associated with increased prevalence of metabolic syndrome." Indian Journal of Medical Research, 126(6), 522.
13. Joshi, S. R. (2003). "Metabolic syndrome—emerging clusters of the Indian phenotype." Journal of Association of Physicians of India, 51, 445-446.
14. Das, M., et al. (2006). "The metabolic syndrome in an Indian urban population: Ahmedabad Study." Journal of Diabetes and its Complications, 20(2), 95-102.
15. Gupta, R., et al. (2012). "Trends in prevalence of coronary heart disease and risk factors over 60 years in India." Indian Heart Journal, 64(3), 274-281.
16. Prabhakaran, D., et al. (2005). "Cardiovascular risk factors for coronary heart disease in two industrial populations in India." Journal of the American College of Cardiology, 45(1), 67-73. (Relevant to the Durgapur cohort).
17. Mandal, S., et al. (2014). "Assessment of metabolic syndrome among industrial workers of West Bengal." Journal of Clinical and Diagnostic Research, 8(11), CC11.
18. Chatterjee, S., et al. (2015). "Prevalence of metabolic syndrome in West Bengal, India." Indian Journal of Endocrinology and Metabolism, 19(1), 123.
19. Ray, S., et al. (2010). "Non-alcoholic fatty liver disease in a tertiary care hospital of Eastern India." Indian Journal of Public Health, 54(3), 161.
20. Dasarathy, S., et al. (2009). "Validity of real time ultrasound in the diagnosis of hepatic steatosis: a multi-observer study." European Journal of Radiology, 70(3), 529-534. (Provides the baseline comparison for MRI/CT superiority).

